Nanalysis Scientific Corp (NSCI)

Currency in CAD
0.1250
0.0000(0.00%)
Closed·
Advertisement
Earnings results expected in 12 days
NSCI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.12500.1250
52 wk Range
0.11000.2450
Key Statistics
Prev. Close
0.125
Open
0.125
Day's Range
0.125-0.125
52 wk Range
0.11-0.245
Volume
179
Average Volume (3m)
38.83K
1-Year Change
-46.8085%
Book Value / Share
0.09
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NSCI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.5000
Upside
+300.00%
Members' Sentiments
Bearish
Bullish
ProTips
Stock price often moves in the opposite direction of the market

Nanalysis Scientific Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 0.5000
(+300.00% Upside)

Nanalysis Scientific Corp Earnings Call Summary for Q1/2026

  • Q1 2026 EPS of -0.01 missed forecast of 0.01; revenue of CAD 10.67M fell 12% short of CAD 12.12M estimate, triggering 6.67% stock decline.
  • Adjusted EBITDA rose 62.2% YoY to CAD 292K; security services margin improved to 19% from 6%, offsetting weak product sales performance.
  • Company pivoting strategy toward high-margin proprietary products, expanding benchtop NMR from R&D to quality control applications.
  • No specific financial guidance provided for upcoming quarters; net loss narrowed slightly to CAD 1.28M from CAD 1.31M in Q1 2025.
  • Earnings call featured no analyst questions, suggesting limited investor confidence; stock trades near 52-week low of 0.11 with CAD 158M market cap.
Last Updated: 21/05/2026, 15:18
Read Full Transcript

Earnings

Latest Release
20/05/2026
EPS / Forecast
-0.01 / 0.01
Revenue / Forecast
10.67M / 12.12M
EPS Revisions
Last 90 days

Compare NSCI to Peers and Sector

Metrics to compare
NSCI
Peers
Sector
Relationship
P/E Ratio
−3.1x−6.9x−0.4x
PEG Ratio
−0.06−0.050.00
Price/Book
1.3x3.2x2.6x
Price / LTM Sales
0.4x15.5x3.0x
Upside (Analyst Target)
300.0%291.3%48.7%
Fair Value Upside
Unlock−4.9%5.6%Unlock

Nanalysis Scientific Corp. develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Europe, Asia, and internationally. The company operates through the Scientific Equipment and Security Services segment. It offers nuclear magnetic resonance (NMR) spectrometers; magnetic resonance test, and measurement and diagnostic system; a 60-NMR platform; 100-NMR platform; 60-TEACH; QUAD NMR Console; and the Cameleon 4 console, a compact alternative to facilitate MRI for teaching. The company also provides software products, such as NMRGui, a user interface for data acquisition and processing of benchtop NMR products; SPINit MR software platform to facilitate data acquisition, processing, and pulse programming; and NMRFx platform that offers a suite of software tools to streamline and automate MR data analysis and management. In addition, it offers security services, including preventive and on-call maintenance services, scheduled preventative maintenance work, corrective maintenance work, installation and upgrade projects for detection and general security equipment; other technical maintenance services; and installation and maintenance services for commercial security equipment, such as scanning devices, metal detectors, detection equipment, and other general security equipment. It serves pharmaceutical, biotechnology, nutraceutical, education, chemical, security, food, oil and gas, materials, life science, medical, and educational industries. Nanalysis Scientific Corp. is headquartered in Calgary, Canada.

Employees
249
Market
Canada

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
9.80M7.08%1.23M
Public Companies & Retail Investors
128.65M92.92%16.08M
Total
138.46M100.00%17.31M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Pathfinder Asset Management Limited7.08%9,804,9441,226

FAQ

What Is the Nanalysis Scientific (TSXV: NSCI) Share Price Today?

The Nanalysis Scientific stock price today is 0.1250 CAD.

What Stock Exchange Does Nanalysis Scientific (NSCI) Trade On?

Nanalysis Scientific is listed and trades on the TSX Venture Exchange.

What Is the Ticker (Stock Symbol) for Nanalysis Scientific?

The stock symbol (also called a 'ticker') for Nanalysis Scientific is "NSCI."

What Is the Current Nanalysis Scientific Market Capitalisation?

As of today, Nanalysis Scientific (TSXV: NSCI) market cap is 17.3100M CAD.

What Is Nanalysis Scientific's (NSCI) Earnings Per Share (TTM)?

The Nanalysis Scientific EPS is currently -0.0495 (Trailing Twelve Months).

When Is the Next Nanalysis Scientific Earnings Date?

Nanalysis Scientific's next earnings report will be released on 20/08/2026.

Is NSCI a Buy or Sell From a Technical Analyst Perspective?

Based on today's Nanalysis Scientific moving averages and other technical indicators, the daily buy/sell signal for NSCI stock is Neutral.

How Many Times Has Nanalysis Scientific Stock Split?

Nanalysis Scientific has split 1 times. (See the NSCI stock split history page for full effective split date and price information.)

How Many Employees Does Nanalysis Scientific Have?

Nanalysis Scientific has 249 employees, based on their latest Companies House report.

What is the current trading status of Nanalysis Scientific (TSXV: NSCI)?

As of 08/08/2026, Nanalysis Scientific (NSCI) is trading at a share price of 0.1250 CAD, with a previous close of 0.1250 CAD. The stock has fluctuated within a day range of 0.1250 CAD to 0.1250 CAD, while its 52-week range spans from 0.1100 CAD to 0.2450 CAD.

What Is Nanalysis Scientific (NSCI) Price Target According to Analysts?

The average 12-month price target for Nanalysis Scientific is 0.5000 CAD, with a high estimate of 0.5 CAD and a low estimate of 0.5 CAD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +300.00% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.